Notice: This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends BASI vs. NOTV, LUNA, ONMD, BIAF, AIKI, DKDCA, ISPC, IQV, ICLR, and INCYShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Inotiv (NOTV), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), IQVIA (IQV), ICON Public (ICLR), and Incyte (INCY). Bioanalytical Systems vs. Inotiv Luna Innovations OneMedNet bioAffinity Technologies AIkido Pharma Data Knights Acquisition iSpecimen IQVIA ICON Public Incyte Bioanalytical Systems (NASDAQ:BASI) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment. Do analysts prefer BASI or NOTV? Inotiv has a consensus target price of $5.92, suggesting a potential upside of 29.75%. Given Inotiv's stronger consensus rating and higher probable upside, analysts plainly believe Inotiv is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is BASI or NOTV more profitable? Bioanalytical Systems has a net margin of -7.75% compared to Inotiv's net margin of -22.10%. Inotiv's return on equity of -15.86% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Bioanalytical Systems-7.75% -42.74% -6.38% Inotiv -22.10%-15.86%-4.03% Do institutionals & insiders hold more shares of BASI or NOTV? 10.6% of Bioanalytical Systems shares are owned by institutional investors. Comparatively, 18.2% of Inotiv shares are owned by institutional investors. 11.5% of Bioanalytical Systems shares are owned by company insiders. Comparatively, 5.8% of Inotiv shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor BASI or NOTV? Bioanalytical Systems received 109 more outperform votes than Inotiv when rated by MarketBeat users. However, 48.72% of users gave Inotiv an outperform vote while only 37.65% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformBioanalytical SystemsOutperform Votes12837.65% Underperform Votes21262.35% InotivOutperform Votes1948.72% Underperform Votes2051.28% Which has preferable earnings & valuation, BASI or NOTV? Bioanalytical Systems has higher earnings, but lower revenue than Inotiv. Bioanalytical Systems is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioanalytical Systems$60.47M0.84-$4.68M-$0.35-13.03Inotiv$490.74M0.24-$108.44M-$4.19-1.09 Does the media refer more to BASI or NOTV? In the previous week, Inotiv had 4 more articles in the media than Bioanalytical Systems. MarketBeat recorded 4 mentions for Inotiv and 0 mentions for Bioanalytical Systems. Inotiv's average media sentiment score of 1.20 beat Bioanalytical Systems' score of 0.00 indicating that Inotiv is being referred to more favorably in the news media. Company Overall Sentiment Bioanalytical Systems Neutral Inotiv Positive Which has more risk and volatility, BASI or NOTV? Bioanalytical Systems has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, Inotiv has a beta of 3.59, indicating that its stock price is 259% more volatile than the S&P 500. SummaryInotiv beats Bioanalytical Systems on 12 of the 18 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.76M$4.27B$5.39B$9.13BDividend YieldN/A1.77%5.37%4.00%P/E Ratio-10.8653.5188.9117.53Price / Sales0.8445.341,290.81137.24Price / Cash558.4027.3736.6032.90Price / Book6.613.434.964.69Net Income-$4.68M$139.50M$117.89M$224.57M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$4.56+6.8%N/A+26.0%$50.76M$60.47M-10.86397Analyst ForecastHigh Trading VolumeNOTVInotiv3.7825 of 5 stars$4.27-1.2%$5.92+38.6%+34.5%$111.06M$490.74M-1.022,075Positive NewsGap DownLUNALuna Innovations1.7331 of 5 stars$1.07+4.9%$8.00+647.7%-84.7%$36.34M$116.61M0.00390Analyst ForecastGap DownONMDOneMedNetN/A$1.16+6.4%N/A+214.0%$32.47M$1.02M0.002BIAFbioAffinity Technologies2.4936 of 5 stars$0.68-6.8%$6.00+788.9%-56.2%$10.52M$2.53M-0.8210Gap UpAIKIAIkido PharmaN/A$1.23+12.8%N/A-44.8%$6.75M$10,000.00-0.324DKDCAData Knights AcquisitionN/A$1.16+6.4%N/A+169.8%$6.00MN/A-6.102Gap DownHigh Trading VolumeISPCiSpecimen1.0083 of 5 stars$2.37-16.8%N/A+406.6%$2.28M$9.93M-0.1260News CoverageGap UpHigh Trading VolumeIQVIQVIA4.7701 of 5 stars$197.25-0.2%$255.82+29.7%-4.7%$35.80B$14.98B25.8987,000Analyst ForecastPositive NewsICLRICON Public4.3259 of 5 stars$198.11-2.2%$287.00+44.9%-21.0%$16.34B$8.12B22.0941,100Analyst RevisionINCYIncyte4.7826 of 5 stars$71.93-0.7%$76.29+6.1%+19.5%$13.86B$3.70B513.822,524 Related Companies and Tools Related Companies Inotiv Competitors Luna Innovations Competitors OneMedNet Competitors bioAffinity Technologies Competitors AIkido Pharma Competitors Data Knights Acquisition Competitors iSpecimen Competitors IQVIA Competitors ICON Public Competitors Incyte Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BASI) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
